Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482010 | SCV000571499 | likely benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000651624 | SCV000773478 | benign | Developmental and epileptic encephalopathy 94 | 2024-11-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000651624 | SCV000896497 | uncertain significance | Developmental and epileptic encephalopathy 94 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002525895 | SCV003688430 | likely benign | Inborn genetic diseases | 2021-11-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre de Biologie Pathologie Génétique, |
RCV001252450 | SCV001428206 | uncertain significance | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |